Q1FY20 Results: Hester Bioscience sales up 11 per cent

The leading animal healthcare companies reported 11 per cent YoY increase in sales at Rs. 42.42 crore for Q1FY20 as against Rs. 38.26 crore in Q1FY19, on a standalone basis. Net Profit was at Rs. 9.79 as against Rs. 9.68 crore in Q1FY19.

On a consolidated basis, the company reported 12.43 per cent YoY increase in sales at Rs. 44.75 crore for Q1FY20 as against Rs. 39.80 crore in Q1FY19. The segment was impacted by rise in maize prices, which led to farmers controlling their spend on health products. Net Profit was at Rs. 8.08 as against Rs. 8.29 crore in Q1FY19.

On a segmental basis, in the first quarter of FY20 the company's Poultry healthcare segment's contribution to sales decreased to 79 per cent from 86 per cent in Q1FY19. Hester Bioscience is the second-largest poultry vaccine manufacture in India. While Animal healthcare's contribution increased to 13 per cent from 9 per cent in Q1FY19.

Meanwhile, the stock of Hester Bioscience opened at Rs. 1689.00 per share on Wednesday and closed at Rs. 1,549.85 per share, down by 7.24 per cent on BSE.